FDA Trial Data Standards Plan Has NDA, BLA Implications

Clinical Trials Advisor
An FDA plan detailing how the agency will develop and implement clinical trial data terminology standards for therapeutic areas (TA), which was released last month, could affect the way drug and biologic applications are reviewed.

To View This Article:


Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00